Special Edition: Time in Range: Medication Management – March 2023
Diabetes Core Update
00:00
Type 2 Diabetes - What's the First Step After Lifestyle Modification?
The 2022 ADAESD algorithm highlights two key goals that really direct rather our selection of glucose-luring therapies. That includes adding agents with evidence of cardiovascular or kidney benefit in people who are at risk to mitigate their heart and kidney risk. And the second main goal is adding agents to achieve and maintain glycemic and weight management goals. The guideline does not give a preference for one class over the other, really based on the absence of head-to-head trials evaluating these two classes and their benefits on ASCVD.
Transcript
Play full episode
